and Paul Sudentas
are speaking at the 12th Annual Paragraph IV Disputes Conference, April 23-24, 2018 in New York.
David is speaking on "Cross-Border Business Considerations in a Hatch-Waxman Scenario," and Paul's topic is "Mastering the Use of Experts in Parallel Proceedings."
Each spring, leading pharmaceutical patent litigators for brand name and generic drug companies gather at the Paragraph IV Disputes conference to discuss, debate, and analyze the latest trends, judicial rulings and legislative developments affecting Hatch-Waxman litigation. As the industry prepares to address the fall out of global pharmaceutical patent losses of billions of dollars on the Hatch-Waxman landscape, the time for this conference has never been more relevant.
For more information, please click here.